Keith L. Klein

Former Secretary & General Counsel at KYTHERA Biopharmaceuticals, Inc.

Keith L. Klein

Keith L. Klein

Former Secretary & General Counsel at KYTHERA Biopharmaceuticals, Inc.

Overview
Career Highlights

KYTHERA Biopharmaceuticals, Inc.
Unity Biotechnology, Inc.
Amgen, Inc.

RelSci Relationships

2905

Birthday

1964

Age

55

Relationships
RelSci Relationships are individuals Keith L. Klein likely has professional access to. A relationship does not necessarily indicate a personal connection.

Venture Partner at ARCH Venture Partners

Relationship likelihood: Strong

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Former Chief Financial Officer & Chief Accounting Officer at Sienna Biopharmaceuticals, Inc.

Relationship likelihood: Strong

Venture Partner at ARCH Venture Partners

Relationship likelihood: Strong

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Chair, Health Care & Life Sciences Practice at Latham & Watkins LLP

Relationship likelihood: Strong

Managing Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Global Chair, International Tax Practice at Latham & Watkins LLP

Relationship likelihood: Strong

Partner at Latham & Watkins LLP

Relationship likelihood: Strong

Office Managing Partner, San Francisco at Latham & Watkins LLP

Relationship likelihood: Strong

Paths to Keith L. Klein
Potential Connections via
Relationship Science
You
Keith L. Klein
Former Secretary & General Counsel at KYTHERA Biopharmaceuticals, Inc.
Education
B.A. in Economics

UCLA's primary purpose as a public research university is the creation, dissemination, preservation and application of knowledge for the betterment of our global society. To fulfill this mission, UCLA is committed to academic freedom in its fullest terms: We value open access to information, free and lively debate conducted with mutual respect for individuals, and freedom from intolerance. In all of our pursuits, we strive at once for excellence and diversity, recognizing that openness and inclusion produce true quality. These values underlie our three institutional responsibilities. Learning and teaching at UCLA are guided by the belief that undergraduate, graduate and professional school students and their teachers belong to a community of scholars. This community is dedicated to providing students with a foundational understanding of a broad range of disciplines followed by the opportunity for in-depth study in a chosen discipline. All members of the community are engaged together in discovering and advancing knowledge and practice. Learning occurs not only in the classroom but also through engagement in campus life and in communities and organizations beyond the university.

J.D

UCLA School of Law is the youngest top law school in the nation. After more than 60 years, our school has never felt bound by outmoded ideas of how law should be taught or studied. Instead, beginning in the 1950s, UCLA created its own tradition - a tradition of innovation.

Career History
Secretary & General Counsel
Current

KYTHERA Biopharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA.

Senior Associate General Counsel
Prior

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

General Counsel
Prior - 2017

Unity Biotechnology, Inc. operates as a biotechnology company engaged in the research and development of therapeutics to extend the human health span. The company was founded by Nathaniel David, Jan van Deursen, Judith Campisi and Daohong Zhou in March 2009 and is headquartered in Brisbane, CA.

Political Donations
$500
2004

Senator from North Carolina

Transactions
Details Hidden

Allergan Plc purchases KYTHERA Biopharmaceuticals, Inc.

Details Hidden

KYTHERA Biopharmaceuticals, Inc. issued Common Stock

Details Hidden

KYTHERA Biopharmaceuticals, Inc. issued Common Stock

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Keith L. Klein. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Keith L. Klein's profile does not indicate a business or promotional relationship of any kind between RelSci and Keith L. Klein.